Pablo J Cagnoni - Net Worth and Insider Trading
Pablo J Cagnoni Net Worth
The estimated net worth of Pablo J Cagnoni is at least $3,767 dollars as of 2024-04-27. Pablo J Cagnoni is the Director of Rubius Therapeutics Inc and owns about 66,082 shares of Rubius Therapeutics Inc (RUBY) stock worth over $3,767. Pablo J Cagnoni is also the Director of CRISPR Therapeutics AG and owns about 0 shares of CRISPR Therapeutics AG (CRSP) stock worth over $0. Details can be seen in Pablo J Cagnoni's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pablo J Cagnoni has not made any transactions after 2023-02-01 and currently still holds the listed stock(s).
Transaction Summary of Pablo J Cagnoni
Pablo J Cagnoni Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pablo J Cagnoni owns 6 companies in total, including Turmeric Acquisition Corp (TMPMU) , Fusion Pharmaceuticals Inc (FUSN) , and Rubius Therapeutics Inc (RUBY) among others .
Click here to see the complete history of Pablo J Cagnoni’s form 4 insider trades.
Insider Ownership Summary of Pablo J Cagnoni
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TMPMU | Turmeric Acquisition Corp | 2020-10-15 | director |
FUSN | Fusion Pharmaceuticals Inc | 2020-06-25 | director |
RUBY | Rubius Therapeutics Inc | 2023-02-01 | director & Chief Executive Officer |
CRSP | CRISPR Therapeutics AG | 2019-11-19 | director |
TMPM | Turmeric Acquisition Corp | 2020-10-15 | director |
INCY | Incyte Corp | 2023-06-07 | President & R&D |
Pablo J Cagnoni Latest Holdings Summary
Pablo J Cagnoni currently owns a total of 2 stocks. Among these stocks, Pablo J Cagnoni owns 66,082 shares of Rubius Therapeutics Inc (RUBY) as of February 1, 2023, with a value of $3,767 and a weighting of 100%. Pablo J Cagnoni also owns 0 shares of CRISPR Therapeutics AG (CRSP) as of November 19, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Pablo J Cagnoni
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RUBY | Rubius Therapeutics Inc | 2023-02-01 | 66,082 | 0.06 | 3,767 |
CRSP | CRISPR Therapeutics AG | 2019-11-19 | 0 | 53.91 | 0 |
Holding Weightings of Pablo J Cagnoni
Pablo J Cagnoni Form 4 Trading Tracker
According to the SEC Form 4 filings, Pablo J Cagnoni has made a total of 4 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 8,448 shares on February 1, 2023, which brought Pablo J Cagnoni around $2,112.
According to the SEC Form 4 filings, Pablo J Cagnoni has made a total of 3 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 7,500 shares on November 19, 2019, which brought Pablo J Cagnoni around $465,000.
Insider Trading History of Pablo J Cagnoni
- 1
Pablo J Cagnoni Trading Performance
GuruFocus tracks the stock performance after each of Pablo J Cagnoni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pablo J Cagnoni is 30.14%. GuruFocus also compares Pablo J Cagnoni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pablo J Cagnoni within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pablo J Cagnoni's insider trading performs compared to the benchmark.
Performance of Pablo J Cagnoni
Average Return
418.61%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 30.58 | 30.14 | 18.39 | 418.61 | -34.19 | -83.4 |
Relative Return to S&P 500(%) | 30.35 | 17.79 | -4.19 | 373.68 | -58.42 | -96.68 |
Pablo J Cagnoni Ownership Network
Ownership Network List of Pablo J Cagnoni
Ownership Network Relation of Pablo J Cagnoni
Pablo J Cagnoni Owned Company Details
What does Turmeric Acquisition Corp do?
Who are the key executives at Turmeric Acquisition Corp?
Pablo J Cagnoni is the director of Turmeric Acquisition Corp. Other key executives at Turmeric Acquisition Corp include Chief Executive Officer Luke Evnin , Chief Financial Officer Edward Hurwitz , and President Todd Foley .
Turmeric Acquisition Corp (TMPMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turmeric Acquisition Corp (TMPMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turmeric Acquisition Corp (TMPMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turmeric Acquisition Corp (TMPMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turmeric Acquisition Corp Insider Transactions
Pablo J Cagnoni Mailing Address
Above is the net worth, insider trading, and ownership report for Pablo J Cagnoni. You might contact Pablo J Cagnoni via mailing address: Onyx Pharmaceuticals, Inc., 249 E. Grand Ave., South San Francisco Ca 94080.